The steep rise in the Automated Compounding Device (Oncology) Market can be ascribed to the emergent need to reduce medicinal errors and a growing preference of cancer patients for personalized ...
FDA has updated Baxter Healthcare’s ExactaMix automated compounding device inlets correction to identify it as a class I recall in which there have been amendments to the product’s instructions for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results